How Clot Composition Influences Fibrinolysis in the Acute Phase of Stroke: A Proteomic Study of Cerebral Thrombi

Author:

Doche Emilie12ORCID,Sulowski Constance12ORCID,Guigonis Jean-Marie3ORCID,Graslin Fanny34ORCID,Casolla Barbara5ORCID,Hak Jean-François6ORCID,Carle Xavier6ORCID,Brunel Hervé6,Lindenthal Sabine3,Martin Jean-Charles2ORCID,Pourcher Thierry3ORCID,Suissa Laurent12,Alessi Marie-Christine,Bobot Mickael,Brinet Abdelmalek,Dagnino Sonia,Dehondt Jean-Daniel,Legge Silvia Di,Dory-Lautrec Philippe,Dulau-Metras Cecile,Durozard Pierre,Kerleroux Basile,Laksiri Nadia,Leclercq Barbara,Lehmann Pierre,Magoncia Ellen,Manzac Christine,Osman Ophelie,Peres Roxane,Perez Sandra,Rey Caroline,Reyre Anthony,Robinet-Borgomano Emmanuelle,Snyman Salome,Svilar Ljubica,Tardivel Catherine,Tourniaire Patricia,Vingadalassalom Sivadji

Affiliation:

1. Stroke Unit, University Hospital La Timone, AP-HM, Marseille, France (E.D., C.S., L.S.).

2. Centre de recherche en CardioVasculaire et Nutrition (C2VN), Marseille, France (E.D., C.S., J.-C.M., L.S.).

3. Laboratory Transporter in Imaging and Radiotherapy in Oncology (TIRO), Direction de la Recherche Fondamentale, Institut des Sciences du Vivant Fréderic Joliot, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, Université Côte d’Azur, School of Medicine, Nice, France (J.-M.G., F.G., S.L., T.P.).

4. Centre Antoine Lacassagne, Nice, France (F.G.).

5. Stroke Unit, CHU Pasteur2, Nice, France (B.C.).

6. Department of Neuroradiology, University Hospital La Timone, AP-HM, Marseille, France (J.-F.H., X.C., H.B.).

Abstract

BACKGROUND: The dramatic clinical improvement offered by mechanical thrombectomy raised questions about the relevance of prior intravenous thrombolysis in large-vessel occlusion strokes. Hence, studying intravenous thrombolysis susceptibility and its dependence on thrombus composition is crucial. We used an observational proteomic study of whole thrombi retrieved by mechanical thrombectomy to identify factors associated with fibrin content and fibrinolytic activity (FA). METHODS: In 104 stroke patients, the thrombi proteome was established by mass spectrometry coupled to liquid chromatography. FA was estimated in clots both outside (FA out ) by measuring D-dimer levels at the blood-thrombus interface and inside (FA in ) by evaluating the ratio of fibrinogen α to its plasmin-cleaved forms using proteomics coupled with protein electrophoresis. The factors associated with fibrin content, FA in , and FA out were determined by intravenous thrombolysis-adjusted linear regression. RESULTS: FA out ( P <0.0001) and FA in ( P =0.0147) were driven by recombinant tissue-type plasminogen activator (r-tPA) administration (47/104) and thrombus composition. Indeed, FA out was greater with fibrin-rich than erythrocyte-rich thrombi, presumably because of more (r)tPA substrates. Thus, FA out was increased with cardioembolic thrombi (72/104), which are rich in fibrin ( P =0.0300). Opposite results were found inside the thrombus, suggesting that (r)tPA penetrability was hampered by the density of the fibrinous cap. Moreover, blood cells had a strong impact on thrombus structure and susceptibility to (r)tPA. Indeed, fibrin content was negatively associated with erythrocyte-specific proteins in the thrombus, admission hematocrit ( P =0.0139), and hemoglobin level ( P =0.0080), which underlines the key role of erythrocytes in thrombus composition. Also, an increased number of neutrophils impaired FA out ( P =0.0225), which suggests that their aggregation around the thrombus prevented the (r)tPA attack. Only FA out was significantly associated with reduced thrombus weight ( P =0.0310), increased recanalization rate ( P =0.0150), good clinical outcome ( P =0.0480), and reduced mortality ( P =0.0080). CONCLUSIONS: Proteomics can offer new insights into the close relationship between thrombus composition and susceptibility to fibrinolysis, paving the way for new adjuvant therapies.

Funder

AMIDEX

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3